Nanomaterials for theranostics: recent advances and future challenges

EK Lim, T Kim, S Paik, S Haam, YM Huh… - Chemical reviews, 2015 - ACS Publications
In 2004, the US Food and Drug Administration (FDA) released an important report entitled
“Innovation/Stagnation: Challenge and Opportunity on the Critical Path to New Medical …

New developments in medical applications of hybrid hydrogels containing natural polymers

C Vasile, D Pamfil, E Stoleru, M Baican - Molecules, 2020 - mdpi.com
New trends in biomedical applications of the hybrid polymeric hydrogels, obtained by
combining natural polymers with synthetic ones, have been reviewed …

Core/shell nanoparticles in biomedical applications

K Chatterjee, S Sarkar, KJ Rao, S Paria - Advances in colloid and interface …, 2014 - Elsevier
Nanoparticles have several exciting applications in different areas and biomedial field is not
an exception of that because of their exciting performance in bioimaging, targeted drug and …

Stimuli-responsive nanogel composites and their application in nanomedicine

M Molina, M Asadian-Birjand, J Balach… - Chemical Society …, 2015 - pubs.rsc.org
Nanogels are nanosized crosslinked polymer networks capable of absorbing large
quantities of water. Specifically, smart nanogels are interesting because of their ability to …

Polymeric nanostructured materials for biomedical applications

Z Tang, C He, H Tian, J Ding, BS Hsiao, B Chu… - Progress in Polymer …, 2016 - Elsevier
Polymeric nanostructured materials (PNMs), which are polymeric materials in nanoscale or
polymer composites containing nanomaterials, have become increasingly useful for …

PNIPAM microgels for biomedical applications: from dispersed particles to 3D assemblies

Y Guan, Y Zhang - Soft Matter, 2011 - pubs.rsc.org
Poly (N-isopropylacrylamide)(PNIPAM) microgel is perhaps the most well-known intelligent
soft nanomaterial. Combining the strengths of hydrogel and nanoparticles, with unique …

Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer

P Yadav, SV Ambudkar, N Rajendra Prasad - Journal of …, 2022 - Springer
Cancer often develops multidrug resistance (MDR) when cancer cells become resistant to
numerous structurally and functionally different chemotherapeutic agents. MDR is …

[HTML][HTML] Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients

R Shi, PY Wang, XY Li, JX Chen, Y Li, XZ Zhang… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Glioma is a most common type of primary brain tumors. Extracellular vesicles, in the form of
exosomes, are known to mediate cell–cell communication by transporting cell-derived …

Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance

M Creixell, NA Peppas - Nano today, 2012 - Elsevier
There are two main mechanisms by which cells become multidrug resistant (MDR): by
increasing drug efflux pumps on the cell membrane and by increasing anti-apoptotic …

Eph receptors and ephrins: therapeutic opportunities

A Barquilla, EB Pasquale - Annual review of pharmacology and …, 2015 - annualreviews.org
The e rythropoietin-p roducing h epatocellular carcinoma (Eph) receptor tyrosine kinase
family plays important roles in developmental processes, adult tissue homeostasis, and …